Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126654161 | 12665416 | 1 | I | 20160811 | 20160818 | 20160818 | EXP | US-ABBVIE-16P-163-1701829-00 | ABBVIE | 0.00 | F | Y | 0.00000 | 20160818 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126654161 | 12665416 | 1 | PS | DEPAKOTE ER | DIVALPROEX SODIUM | 1 | Oral | U | UNKNOWN | 21168 | 500 | MG | BID | ||||||
| 126654161 | 12665416 | 2 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | 20 | MG | TABLET | QD | ||||||||
| 126654161 | 12665416 | 3 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 | 40 | MG | BID | |||||||||
| 126654161 | 12665416 | 4 | C | BUSPIRONE HCL | BUSPIRONE HYDROCHLORIDE | 1 | 0 | 40 | MG | TABLET | BID | ||||||||
| 126654161 | 12665416 | 5 | C | LYRICA | PREGABALIN | 1 | Oral | CAPS | 0 | 75 | MG | QD | |||||||
| 126654161 | 12665416 | 6 | C | ASPIRIN E.C | ASPIRIN | 1 | 0 | 81 | MG | COATED TABLET | QD | ||||||||
| 126654161 | 12665416 | 7 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 | 20 | MG | TABLET | QD | ||||||||
| 126654161 | 12665416 | 8 | C | AMOXICILLIN. | AMOXICILLIN | 1 | 0 | 875 | MG | TABLET | BID | ||||||||
| 126654161 | 12665416 | 9 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0 | .1 | MG | BID | ||||||||
| 126654161 | 12665416 | 10 | C | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | Oral | 0 | .5 | DF | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126654161 | 12665416 | 1 | Product used for unknown indication |
| 126654161 | 12665416 | 2 | Product used for unknown indication |
| 126654161 | 12665416 | 3 | Product used for unknown indication |
| 126654161 | 12665416 | 4 | Product used for unknown indication |
| 126654161 | 12665416 | 5 | Product used for unknown indication |
| 126654161 | 12665416 | 6 | Product used for unknown indication |
| 126654161 | 12665416 | 7 | Product used for unknown indication |
| 126654161 | 12665416 | 8 | Product used for unknown indication |
| 126654161 | 12665416 | 9 | Product used for unknown indication |
| 126654161 | 12665416 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126654161 | 12665416 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126654161 | 12665416 | Back pain | |
| 126654161 | 12665416 | Cellulitis | |
| 126654161 | 12665416 | Depression | |
| 126654161 | 12665416 | Hyperlipidaemia | |
| 126654161 | 12665416 | Hypertension | |
| 126654161 | 12665416 | Myalgia | |
| 126654161 | 12665416 | Obesity | |
| 126654161 | 12665416 | Otitis media | |
| 126654161 | 12665416 | Persistent depressive disorder | |
| 126654161 | 12665416 | Polyneuropathy | |
| 126654161 | 12665416 | Sinusitis | |
| 126654161 | 12665416 | Synovial cyst | |
| 126654161 | 12665416 | Tobacco abuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |